3
Announcements
Trials
Browse
Landscape
Phase
Phase 2/3
1
Status
Recruiting
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other solid neoplasm
1
Conditions
Carcinoma, Non-Small-Cell Lung
13
Lung Neoplasms
2
Esophageal Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
1
Small Cell Lung Carcinoma
1
Sjogren's Syndrome
1
Scleroderma, Systemic
1
Retinoblastoma
1
Resectable Stage II-III Non-Small Cell Lung Cancer (NSCLC)
1
Resectable Non-small Cell Lung Cancer
1
Resectable Lung Non-Small Cell Carcinoma
1
Recurrence
1
Psoriasis
1
Ovarian Neoplasms
1
Neoplasms
1
Neoplasm Metastasis
1
Multiple Sclerosis
1
Lupus Erythematosus, Systemic
1
Inflammatory Bowel Diseases
1
Hematologic Neoplasms
1
Dermatomyositis
1
Crohn Disease
1
Colitis, Ulcerative
1
Carcinoma, Ovarian Epithelial
1
Carcinoma, Bronchogenic
1
Bronchial Neoplasms
1
Autoimmune Diseases
1
Arthritis, Rheumatoid
1
Arthritis, Psoriatic
1
Advanced Non-small Cell Lung Cancer
1
Interventions
Melphalan
4
Vincristine
3
Topotecan
3
Etoposide
3
Carboplatin
3
abemaciclib
1
Wechsler Scales
1
Watchful Waiting
1
Specimen Handling
1
Platinum Compounds
1
Microscopy, Acoustic
1
Memory and Learning Tests
1
Magnetic Resonance Spectroscopy
1
Hyperthermia, Induced
1
Dynamic Contrast Enhanced Magnetic Resonance Imaging
1
Drug Therapy
1
Cryotherapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Retinoblastoma
×
Platinum Compounds
×
Clear all
NCT04681417
2025-11-28
RETINO 2018
Institut Curie
Phase 2/3
Recruiting
225 enrolled